Identification of a genotoxic mechanism for 2-nitroanisole carcinogenecity and of its carcinogenic potential for humans

Carcinogenesis

Volumn 25, Issue 5, 2004, Pages 833-840

  Stiborová, Marie ^a   Mikšanová, Markéta ^a   Smrček, Stanislav ^a   Bieler, Christian A ^b   Breuer, Andrea ^b   Klokow, Karl A ^b   Schmeiser, Heinz H ^b   Frei, Eva ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANILINE DERIVATIVE; ANISOLE; DEOXYGUANOSINE; HYDROXYLAMINE; PHOSPHORUS 32; TRITIUM; XANTHINE OXIDASE;

ARTICLE; BLADDER; BLADDER CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; COVALENT BOND; CYTOSOL; DNA ADDUCT; DNA BINDING; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; ISOTOPE LABELING; KIDNEY; LIVER; MALE; METABOLITE; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; RAT; REDUCTION; SPLEEN;

ADOLESCENT; ADULT; AGED; ALDEHYDE OXIDASE; ANILINE COMPOUNDS; ANIMALS; ANISOLES; CARCINOGENS; CHILD; CHILD, PRESCHOOL; CYTOSOL; DNA; DNA ADDUCTS; FEMALE; HUMANS; KIDNEY; LIVER; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PHOSPHORUS ISOTOPES; RATS; RATS, WISTAR; SPLEEN; URINARY BLADDER; XANTHINE OXIDASE;

EID: 2442591769     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh061     Document Type: Article

References (55)

1. Garner ,R.C., Martin, C.N. and Clayson, D.B. (1984) Carcinogenic aromatic amines and related compounds. In Searle,C. (ed.), Chemical Carcinogens, 2nd Edn, Vol. 1, CS Monograph 182. American Chemical Society, Washington, DC, pp. 175-302.
2. IARC (1989) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, no. 46, Diesel and Gasoline Engine Exhausts and Some Nitroarenes. IARC, Lyon.
3. Purohit, V. and Basu, A. (2000) Mutagenicity of nitroaromatic compounds. Chem. Res. Toxicol., 13, 673-692.
4. Sabbioni, G. and Jones, C.R. (2002) Biomonitoring arylamines and nitroarenes. Biomarkers, 7, 347-421.
5. El-Bayoumy ,K., Desai ,D., Boyiri, T., Rosa, J., Krzeminski, J., Sharma ,A.K., Pittman, B. and Amin, S. (2002) Comparative tumorigenicity of the environmental pollutant 6-nitrochrysene and its metabolites in the rat mammary gland. Chem. Res. Toxicol., 15, 972-978.
6. Cui, X.S., Bergman, J. and Moller, L. (1996) Preneoplastic lesions, DNA adduct formation and mutagenicity of 5-, 7- and 9-hydroxy-2-nitrofluorene, metabolites of the air pollutant 2-nitrofluorene. Mutat. Res., 369, 147-155.
7. Ritter ,C.L., Culp, S.J., Freeman ,J.P., Marques ,M.M., Beland, F.A. and Malejka-Giganti, D. (2002) DNA adducts from nitroreduction of 2,7-dinitrofluorene, a mammary gland carcinogen, catalyzed by rat liver or mammary gland cytosol. Chem. Res. Toxicol., 15, 536-544.
8. Cui, X.S., Eriksson, L.C. and Moller, L. (1999) Formation and persistence of DNA adducts during and after a long-term administration of 2-nitrofluorene. Mutat. Res., 442, 9-18.
9. Ritter, C.L., Decker, R.W. and Malejka-Giganti ,D. (2000) Reaction of nitro and 9-oxo groups of environmental nitrofluorenes by the rat mammary gland in vitro. Chem. Res. Toxicol., 13, 793-800.
10. NTP (1993) Toxicology and Carcinogenesis. Studies of o-Nitroanisole. NTP Technical Report 416. US Department of Health and Human Services, Washington, DC.
11. NTP (1978) Bioassay of o-Anisidine Hydrochloride for Possible Carcinogenicity. NTP Technical Report 89. US Department of Health and Human Services, Washington, DC.
12. Traupe, H., Menge, G., Kandt, I. and Karmaus, W. (1997) Higher frequency of atopic dermatitis and decrease in viral warts among children exposed to chemicals liberated in a chemical accident in Frankfurt, Germany. Dermatology, 195, 112-118.
13. Hengstler, J.G., Fuchs, J., Bolmaudorff, U., Meyer, S. and Oesch ,F. (1995) Single-strand breaks in deoxyribonucleic acid in fire fighters accidentally exposed to o-nitroanisole and other chemicals. Scand. J. Work Environ. Health, 21, 36-42.
14. Fu, P.P. (1990) Metabolism of nitro-polycyclic aromatic hydrocarbons. Drug Metab. Rev., 22, 209-268.
15. Bieler, C.A., Wiessler, M., Erdinger, L., Suzuki, H., Enya, T. and Schmeiser, H.H. (1999) DNA adduct formation from the mutagenic air pollutant 3-nitrobenzanthrone. Mutat. Res., 439, 307-311.
16. Stiborová ,M., Frei, E., Wiessler ,M. and Schmeiser, H.H. (2001) Human enzymes involved in metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem. Res. Toxicol., 14, 1128-1137.
17. Stiborová, M., Frei, E., Sopko, B., Wiessler, M. and Schmeiser, H.H. (2002) Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis, 23, 617-625.
18. Arlt, V.M., Stiborová ,M., Hewer, A., Schmeiser, H.H. and Phillips, D.H. (2003) Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome P450. Cancer Res., 63, 2752-2761.
19. Stiborová, M., Frei, E., Sopko, B., Sopková, K., Marková, V., Laňková, M., Kumstýř ová, T., Wiessler, M. and Schmeiser, H.H. (2003) Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P H:quinone oxidoreductase. Carcinogenesis, 24, 1695-1703.
20. Hein, D.W., Doll, M.A., Fretland, A.J., Gray ,K., Deitz, A.C., Feng, Y., Jiang, W., Rustan, T.D., Satran, S. and Wilkie, T.R. (1997) Rodent models of the human acetylation polymorphism: comparison of recombinant acetyltransterases. Mutat. Res., 376, 101-106.
21. Glatt, H. (2000) Sultotransferases in the bioactivation of xenobiotics. Chem. Biol. Interact., 129, 141-170.
22. Arlt, V.M., Glatt, H., Muckel ,E., Pabel, U., Sorg, B.L., Schmeiser ,H.H. and Phillips, D.H. (2002) Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase. Carcinogenesis, 23, 1937-1945.
23. Arlt, V.M., Glatt, H., Muckel, E., Pabel, U., Sorg, B.L., Seidel, A., Frank, H., Schmeiser, H.H. and Phillips, D.H. (2003) Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells. Int. J. Cancer, 105, 583-592.
24. Miller ,M.J., Sipes, I.G., Perry, D.F. and Carter, D.E. (1985) Pharmacokinetics of o-nitroanisole in Fischer 344 rats. Drug Metab. Dispos., 13, 527-531.
25. Stiborová, M., Mikšanová, M., Schmeiser ,H.H., Wiessler, M. and Frei, E. (2001) Towards the explanation of the carcinogenicity of 2-nitroanisole and 2-anisidine, carcinogens with unknown mechanism. J. Cancer Res. Clin. Oncol., 127, S31.
26. Mikšanová ,M., Novák, P., Frei, E. and Stiborová ,M. (2004) Metabolism of carcinogenic 2-nitroanisole by rat, rabbit, porcine and human hepatic cytosol. Collect. Czech. Chem. Commun., 69, 589-602.
27. Stiborová ,M., Schmeiser ,H.H. and Frei, E. (1998) To the mechanism of 2-nitroanisole carcinogenicity: in vitro metabolism of 2-nitroanisole mediated by peroxidases and xanthine oxidase. Collect. Czech. Chem. Commun., 63, 857-869.
28. Balaban, A.T., Garfield ,R.E., Lesko ,M.J. and Seitz, W.A. (1998) Synthesis and spectral data of some new N-nitroso-N-phenylhydroxylamine (cupferron) derivatives. Org. Prep. Proced. Int., 30, 439-446.
29. Sakaue ,S., Tsubakino, T., Nishiyama, Y. and Ishii, Y. (1993) Oxidation of aromatic-amines with hydrogen-peroxide catalyzed by cetylpyridinium heteropolyoxometalates. J. Org. Chem., 58, 3633-3638.
30. Schmeiser, H.H., Bieler ,C.A., Wiessler ,M., van Ypersele de Strihou, C. and Cosyns, J.-P. (1996) Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res., 56, 2025-2028.
31. 32P-post-labeling: evidence for reductive activation by peroxidases. Carcinogenesis, 18, 1055-1062.
32. Stiborová ,M., Hájek ,M., Vošmiková, H., Frei, E. and Schmeiser ,H.H. (2001) Isolation of DT-diaphorase [NAD(P)H dehydrogenase (quinone)] from rat liver cytosol: identification of new enzyme substrates, carcinogenic aristolochic acids. Collect. Czech. Chem. Commun., 66, 959-972.
33. Yamazoe ,Y., Zenser ,T.V., Miller, D.W. and Kadlubar ,F.F. (1988) Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. Carcinogenesis, 9, 1635-1641.
34. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
35. 32P-adduct assay comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis, 8, 1687-1693.
36. Stiborová ,M., Mikšanová ,M., Havlíč ek, V., Schmeiser ,H.H. and Frei ,E. (2002) Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA. Mutat. Res., 500, 49-66.
37. Reddy, M.V., Bleicher, W.T., Blackburn ,G.R. and Mackerer ,E.R. (1990) DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo. Carcinogenesis, 8, 1349-1357.
38. 32P-postlabeling analysis of DNA adduct formation. Mutat. Res., 493, 153-164.
39. 32P-labeled nucleoside 3′,5′-bisphosphate adducts of polycyclic aromatic hydrocarbons. J. Chromatogr., 570, 65-76.
40. 32P-postlabeling analysis using different chromatographic procedures. Carcinogenesis, 15, 1187-1192.
41. 32P-postlabeling and high pressure liquid chromatographic analyses for 7,12-dimethylbenz[a]anthracene-DNA adducts. Carcinogenesis, 9, 633-638.
42. 32P-postlabeling analysis of nonradioactive aromatic carcinogen-DNA adducts. Carcinogenesis, 3, 1081-1092.
43. Stiborová, M., Martínek, V., Rýdlová, H., Hodek ,P. and Frei ,E. (2002) Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes. Cancer Res., 62, 5678-5684.
44. Stiborová ,M., Asfaw, B., Frei, E., Schmeiser, H.H. and Wiessler ,M. (1995) Benzenediazonium ion derived from Sudan I forms an 8-(phenylazo)-guanine adduct in DNA. Chem. Res. Toxicol., 8, 489-498.
45. 32P-postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies. Chem. Res. Toxicol., 12, 661-669.
46. 32P-postlabeling efficiencies of 2,6-dimethylaniline-DNA adducts. Chem. Res. Toxicol., 14, 165-174.
47. Sarnesto ,A., Linder, N. and Raivio, K.O. (1996) Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein. Lab. Invest., 74, 48-56.
48. Pristos ,C.A. (2000) Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem.-Biol. Interact., 129, 195-208.
49. Sakela, M., Lapatto, R. and Raivio, K.O. (1998) Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues. Biol. Neonate, 74, 274-280.
50. Jarasch ,E.-D., Bruder, G. and Heid ,H.W. (1986) Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol. Scand., 548, 39-46.
51. Moriwaki ,Y., Yamamoto ,T., Suda, M., Nasako ,Y., Takahashi, S., Agbedana,O.E., Hada,T. and Higashino,K. (1993) Purification and immunohistochemical tissue localization of human xanthine oxidase. Biochim. Biophys. Acta, 1164, 327-330.
52. Vickers, S., Schiller, H.J., Hildreth ,J.E.K. and Bulkley, G.B. (1998) Immunoaffinity localization of the enzyme xanthine oxidase on the outside surface of the endothelial cell plasma membrane. Surgery, 124, 551-560.
53. Kadlubar ,F.F. and Badawi ,A.F. (1995) Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett., 82, 627-632.
54. Willey, J.C., Coy, E., Brolly, C., Utell ,M.J., Frampton, M.W., Hammersley, J., Thilly W.G., Olson, D. and Cairs ,K. (1996) Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am. J. Respir. Cell Mol. Biol., 14, 262-271.
55. Richard ,K., Hume, R., Kaptein ,E., Stanley ,E.L., Visser, T.J. and Coughtrie, M.W.H. (2001) Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung and brain. J. Clin. Endocrinol. Metab., 86, 2734-2742.